# Adaptimmune Therapeutics PLC: Form 8-K, filed May 14, 2021

- Company: [Adaptimmune Therapeutics PLC](/companies/adapy.md) (CIK 1621227)
- Form: 8-K
- Filed: 2021-05-14
- Accepted by EDGAR: May 14, 2021, 08:39 ET
- Period: 2021-05-14
- Accession: 0001104659-21-066437
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1621227/000110465921066437/tm2116257d1_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1621227/000110465921066437/

## Items reported

- Item 5.07: Shareholder vote results

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1621227/000110465921066437/tm2116257d1_8k.htm

Filed May 14, 2021.
Source: SEC EDGAR, the filing index for accession 0001104659-21-066437. Last ingested by Listed: Oct 24, 2026, 15:14 ET. No prices; not investment advice.
